logo
#

Latest news with #Screening

Cher's Fans Will Apparently Love Her Music ‘Forever'
Cher's Fans Will Apparently Love Her Music ‘Forever'

Forbes

time02-04-2025

  • Entertainment
  • Forbes

Cher's Fans Will Apparently Love Her Music ‘Forever'

Cher's Forever compilation returns to two U.K. charts, landing at No. 65 on both, thanks to a vinyl ... More sale that reignites fan demand. LOS ANGELES, CALIFORNIA - APRIL 16: Cher attends the Los Angeles Special Screening of Searchlight Pictures' "Chevalier" at El Capitan Theatre on April 16, 2023 in Los Angeles, California. (Photo by Axelle/Bauer-Griffin/FilmMagic) It seems like the world will never tire of Cher or her music. The iconic singer and actress has been delivering hits for decades, and somehow, the appeal of her vast catalog only continues to grow. That sustained interest has powered numerous compilations over the decades, and this week, one of her most recent efforts is surging. Forever, a career-spanning set that showcases Cher's many musical eras and gives listeners a title to focus on when heading to streaming platforms, returns to the charts in the U.K. this week. Forever is a hit once more this week, as it finds its way back onto a pair of U.K. rankings. This time around, the set reappears on both the Official Albums Sales and the Official Physical Albums charts. In a fun coincidence, it lands in the same spot on each tally, at No. 65. Cher's Forever has maintained a pattern on these two tallies throughout its lifetime. When it first arrived last year, it debuted at No. 11 on both the Official Albums Sales and Official Physical Albums charts. Forever has also now spent exactly 13 weeks on each ranking. Forever hasn't been absent from these rosters for long. The last time it was seen on either list was just a few months ago, during the final chart week of January 2025. The collection initially debuted across several U.K. rankings in October 2024, not long after it was released. On the main all-genre tally — the Official Albums chart — Forever only managed a brief appearance, opening at No. 44 and then falling away. It narrowly missed becoming another top 40 win for Cher in the country. What's behind this renewed attention being paid to Cher's compilation? It appears that Forever saw a spike in sales after being offered at a discount. Vinyl editions of the set — including eye-catching 2LP versions in silver and sea blue — were marked down on Amazon in the U.K. That sale seems like it may have been enough to push the title back to the charts.

GO2 for Lung Cancer Forms the Global Advisory Council to Support Its Mission to Confront Lung Cancer
GO2 for Lung Cancer Forms the Global Advisory Council to Support Its Mission to Confront Lung Cancer

Associated Press

time25-03-2025

  • Health
  • Associated Press

GO2 for Lung Cancer Forms the Global Advisory Council to Support Its Mission to Confront Lung Cancer

'The diverse range of experiences, expertise, and perspectives this group offers plays a crucial role in advancing our work.' — GO2 for Lung Cancer President and CEO Laurie Ambrose WASHINGTON, DC, UNITED STATES, March 25, 2025 / / -- GO2 for Lung Cancer (GO2) announced it established the Global Advisory Council (GAC), a new group that brings together scientists, medical specialists, and other healthcare professionals from diverse disciplines who focus on GO2's areas of impact: healthcare delivery, patient education, policy, and research. The GAC provides recommendations to guide GO2's program and project development. 'The GAC is an invaluable resource as GO2 for Lung Cancer continues its long-standing mission to increase survival and quality of life for those at risk, diagnosed, and living with lung cancer,' said GO2's President and CEO Laurie Ambrose. 'The diverse range of experiences, expertise, and perspectives this group offers plays a crucial role in advancing our work.' The GAC is the evolution of GO2's Scientific Leadership Board into a broader, multidisciplinary group. While science remains the core foundation, the diversified expertise of GAC members better addresses emerging challenges in lung cancer care, screening access, and patient advocacy. 'I am excited to collaborate with GO2 and colleagues who bring a depth of lung cancer expertise that spans a range of specialties,' said Memorial Cancer Institute's Chief Scientific Officer and Medical Director, Luis E. Raez, MD, FACP, FCCP. 'The GO2 Global Advisory Council is critical to ensuring that we continue to address the needs of the lung cancer community.' As the world's leading organization dedicated to transforming lung cancer survivorship, GO2 is dedicated to saving, extending, and improving the lives of those vulnerable, at risk, and diagnosed with lung cancer. GAC's members play a pivotal role in advancing GO2's mission and achieving its key objectives: - Increase the number of lung cancers diagnosed early - Increase the rate of biomarker testing and use of precision medicine - Increase the impact of community engagement - Improve quality of life Current members of the GO2 Global Advisory Council include: Trever Bivona, MD, PhD; Professor of Medicine; University of California, San Francisco Hossein Borghaei, DO, MS; Professor and Chief, Thoracic Oncology; Fox Chase Cancer Center Debra S. Dyer, MD, FACR; Professor and Chair, Department of Radiology; National Jewish Health Jan M. Eberth, PhD, FACE; Professor and Chair, Health Management and Policy; Drexel University Jhanelle E. Gray, MD; Chair, Thoracic Oncology; Moffitt Cancer Center Karen Kelly, MD; Chief Executive Officer; International Association for the Study of Lung Cancer Christine M. Lovly, MD, PhD, FASCO; Associate Professor of Medicine, Hematology and Oncology; Vanderbilt University Medical Center William R. Mayfield, MD, FACS; Medical Director, Lung Cancer Screening and Incidental Nodule Programs; Wellstar Health System Peter Mazzone, MD, MPH, FCCP; Head, Thoracic Oncology Program, Pulmonary Department; Cleveland Clinic Kathryn F. Mileham, MD, FACP; Co-Lead, Lung Cancer Disease Group and Chief, Thoracic Medical Oncology Section; Atrium Health – Levine Cancer Institute Drew Moghanaki, MD, MPH; Professor and Chief of Thoracic Oncology; David Geffen School of Medicine at UCLA Ray U. Osarogiagbon, MBBS, FACP; Chief Scientist; Baptist Memorial Healthcare Corporation Jamie S. Ostroff, PhD; Chief, Behavioral Sciences Service; Memorial Sloan Kettering Cancer Center Luis E. Raez, MD, FACP, FCCP; Chief Scientific Officer & Medical Director; Memorial Cancer Institute Natasha Rekhtman, MD, PhD; Attending Pathologist, Thoracic Pathology & Cytopathology; Memorial Sloan Kettering Cancer Center Alison Mayer Sachs, MSW, LSW, CSW, OSW-C, FAOSW; Cancer Support Services Consultant Pamela Samson, MD, MPHS; Assistant Professor, Department of Radiation Oncology; Washington University in Saint Louis Jacob Sands, MD; Physician; Dana-Farber Cancer Institute Kerri B. Susko, LISW-CP, OSW-C; Counselor, Center for Integrative Oncology and Survivorship & Director, Cancer Support Community; Prisma Health Cancer Institute Jennifer Temel, MD; Professor of Medicine; Massachusetts General Hospital Douglas E. Wood, MD, FACS, FRCSEd; The Henry N. Harkins Professor and Chair, Department of Surgery; University of Washington ABOUT GO2 FOR LUNG CANCER GO2 for Lung Cancer relentlessly confronts lung cancer on every front, every day, for everyone. Founded by patients and survivors, GO2 is dedicated to increasing survival and quality of life for those at risk, diagnosed, and living with lung cancer. For more information, visit Facebook (@GO2forLungCancer), Instagram, X (formerly Twitter, @go2forlungcancr), and LinkedIn (@go2forlungcancer). Julia Spiess X LinkedIn Instagram YouTube Legal Disclaimer:

Tontitown public hearing requested against Eco-Vista Landfill air permit request
Tontitown public hearing requested against Eco-Vista Landfill air permit request

Yahoo

time28-02-2025

  • Health
  • Yahoo

Tontitown public hearing requested against Eco-Vista Landfill air permit request

TONTITOWN, Ark. (KNWA/KFTA) — Tontitown residents have requested a public hearing against Eco-Vista Landfill's air permit application to the Arkansas Department of Environmental Quality (ADEQ). The hearing follows an ongoing controversy between Eco-Vista and the city of Tontitown. Recent air studies in the last year have shown toxins in the air significantly higher than the United States Environmental Protection Agency's recommendation for safe levels. Timeline: Tontitown's landfill controversy According to studies conducted through the Center for Toxicology and Environment of Health, the following levels were found in certain sites surrounding the Tontitown landfill: Acrolein was found to be 4,900% over the Regional Screening Level (RSL) Threshold in one spot Benzene was found in one area at 209% over the RSL Cholorform, Naphthalene, and Carbon tetrachloride were also detected more sparingly than the other two chemicals, but still exceeded RSL levels at certain surrounding sites. You can find a more in-depth look at the chemical numbers here. In the most recent development, Eco-Vista applied for an air permit, which, if accepted, would allow the landfill to release a limited amount of air pollutants. Over the years, the people of Tontitown expressed concern over their health and believed sickness in the city is due to air pollution through the landfill. The public hearing with the ADEQ is scheduled for Feb. 27 to address the public's concerns over the air permit. This is a developing story. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store